The Information Supply Chain: Facilitating Outcome Based Pricing
According to an August 9th, 2016 article by Reuters, Analysis-Future of Drug Pricing: Paying for Benefits not per Pill, it was stated “..shifting the overall industry to a new model (paying for clinical outcomes) requires improvements in data collection and a change in thinking..”. The article later stated that, “Drug companies and healthcare providers will …
Drug Recalls
Whether you are a pharmacist, wholesaler, or manufacturer, you realize that the medication recall process requires drastic improvement. I have experienced this first hand as a pharmacist. There were several times when patients would come to the pharmacy and tell me they heard their medication was recalled; I hadn’t even received a fax notification about …
Advancing Patient Adherence: Leveraging Serialization & ADLT™ from Manufacturer to Patient
According to a 2014 Whitepaper by The ThomsenGroup, “.. non-adherence with prescription regimens is now a $300 billion problem in the US. The NCBI (National Center for Biotechnology Information )..noted that almost 50% of all prescribed medications are not taken according to directions…and nearly 25% are never initiated.” Non-adherence is problematic both from a National …